Vanberra Signal
Free trial

Bioprognos

Curated by Signal

Provider of Algorithm-based prognostic tests for the detection of cancer

Life Sciences Technologybioprognos.com

Overview

Provider of Algorithm-based prognostic tests for the detection of cancer. Its proprietary algorithm takes into consideration the presence of curated biomarkers and combines it with other factors such as lifestyle, age, and radiology imaging results to give a prognosis for patients. The current product line includes solutions for lung cancer, ovarian cancer, bladder, breast, colorectal, esophageal, gallbladder, kidney, liver, pancreas, prostate, stomach, testicular, and thyroid cancers.

Key facts

Founded
2016
Headquarters
Barcelona, Spain
Stage
Sign up to view
Industry
Life Sciences Technology

Contact

Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Autoresp Med

    Provider of medical equipment with a focus on respiratory devices

    Life Sciences TechnologyBarcelona, Spain

  • ELLA

    Provider of bioinformatics software for genome data analysis

    Life Sciences TechnologySpain

  • Blast2GO

    Gene Ontology annotation, visualization and analysis tool for functional genomics research

    Life Sciences TechnologyValencia, Spain

About Bioprognos

What does Bioprognos do?

Provider of Algorithm-based prognostic tests for the detection of cancer.

Where is Bioprognos headquartered?

Bioprognos is headquartered in Barcelona, Spain.

When was Bioprognos founded?

Bioprognos was founded in 2016.

Which sector is Bioprognos in?

Bioprognos operates in Life Sciences Technology.

Who are Bioprognos's competitors?

Companies similar to Bioprognos include Autoresp Med, ELLA, and Blast2GO.